Publications by authors named "Emily Engel"

Claim this Profile
C
Characterizing Musculoskeletal Sequelae in Ebola Virus Survivors During the 7 Years Since Hospital Discharge in Eastern Sierra Leone.
Anna C Sanford, Nell G Bond, Emily J Engel, Foday Alhasan, Michael Gbakie

Open Forum Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Meta-Analysis of Female Reproductive Health Following Ebola Virus Disease.
Madison Drogy, Celia Glezer, Emily Engel, Nell Bond, Keith Pickett

Am J Trop Med Hyg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean Cohort.
Nell G Bond, Kayla R Shore, Emily J Engel, Erin E Coonan, Foday Al-Hasan

J Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fremanezumab-associated injection site alopecia.
Mark Esguerra, Emily Rubenstein Engel

BMJ Case Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amelioration of trichotillomania with onabotulinumtoxinA for chronic migraine.
Emily Rubenstein Engel, Jeremy-Ann Ham

BMJ Case Rep· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study.
Donald S Grant, Emily J Engel, Nicole Roberts Yerkes, Lansana Kanneh, James Koninga

PLoS Negl Trop Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone.
Samuel C Ficenec, Donald S Grant, Ibrahim Sumah, Foday Alhasan, Mohamed S Yillah, Emily J Engel

BMC Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Ebola Syndrome Presents With Multiple Overlapping Symptom Clusters: Evidence From an Ongoing Cohort Study in Eastern Sierra Leone.
Nell G Bond, Donald S Grant, Sarah T Himmelfarb, Emily J Engel, Foday Al-Hasan

Clin Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response.
Yolanda Botti-Lodovico, Parvathy Nair, Dolo Nosamiefan, Matthew Stremlau, Stephen Schaffner, Emily J Engel

Viruses· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Space-Time Trends in Lassa Fever in Sierra Leone by ELISA Serostatus, 2012-2019.
Jeffrey G Shaffer, John S Schieffelin, Mambu Momoh, Augustine Goba, Lansana Kanneh, Emily J Engel

Microorganisms· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ophthalmic manifestations and vision impairment in Lassa fever survivors.
Alexa L Li, Donald Grant, Michael Gbakie, Lansana Kanneh, Ibrahim Mustafa, Emily Engel

PLoS One· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever.
Lucy E Horton, Robert W Cross, Jessica N Hartnett, Emily J Engel, Saori Sakabe

Emerg Infect Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lassa Fever among Children in Eastern Province, Sierra Leone: A 7-year Retrospective Analysis (2012-2018).
Robert J Samuels, Troy D Moon, Joseph R Starnes, Foday Alhasan, Michael Gbakie, Emily J Engel

Am J Trop Med Hyg· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IM ketorolac vs diclofenac potassium powder for oral solution for the acute treatment of severe migraine: a randomized controlled trial.
Emily Rubenstein Engel, Joshua Cheng

Neurol Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine.
Emily Rubenstein Engel, David Kudrow, Alan M Rapoport

Neurol Sci· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis